A Phase 3 Study to Evaluate Combination Therapy With Daclatasvir and Sofosbuvir in the Treatment of HIV and Hepatitis C Virus Coinfection.

Completed · Phase 3

Conditions studied: Hepatitis C

In brief

A study of the efficacy and safety of the combination of daclatasvir and sofosbuvir in the treatment of hepatitis C virus and HIV coinfection.

Key facts

Study ID
NCT02032888
Run by
Bristol-Myers Squibb
People needed
238
Starts
2014-02-01
Expected to finish
2015-01-01
Last updated by the study team
2015-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.